References
- US Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease. National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD, USA (2009).
- Chertow GM, Burdick E, Honour M, Bnventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol.16(11), 3365–3370 (2005).
- Korkeila M, Ruokonen E, Takala J. Goals of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med.26(12), 1824–1831 (2000).
- Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J. Am. Soc. Nephrol.14(8), 2178–2187 (2003).
- Kellum JA, Mehta RL, Levin A et al. Development of clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi-process. Clin. J. Am. Soc. Nephrol.3(3), 887–894 (2008).
- Mishra J, Dent C, Trabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute kidney injury after cardiac surgery. Lancet365(9466), 1231–1238 (2005).
- McIllroy DR, Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin. J. Am. Soc. Nephrol.5(2), 211–219 (2010).
- Liangos O, Tighiouart H, Perianayagam MC et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers14(6), 423–431 (2009).
- Cruz DN, de Cal M, Garzotto F et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med.36(3), 444–451 (2010).
- Kumpers P, Hafer C, Lukasz A et al. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit. Care14(1), R9 (2010).
- de Geus HR, Bakker J, Lesaffre EM, le Noble JL. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am. J. Respir. Crit. Care Med.183(7), 907–914 (2011).
- Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J. Am. Soc. Nephrol.16(10), 3046–3052 (2005).
- Siew E, Ikizler TA, Gebretsadik T et al. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin. J. Am. Soc. Nephrol.5(8), 1497–1505 (2010).
- Nejat M, Pickering JW, Walker RJ, Endre ZH. Rapid detection of acute kidney injury by plasma cystatin C in intensive care unit. Nephrol. Dial. Transplant.25(10), 3283–3289 (2010).
- Hollmen ME, Kyllönen LE, Inkinen KA, Lalla ML, Salmela KT. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int.79(1), 89–98 (2011).
- Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers of delayed graft function following kidney transplantation. Am. J. Transplant.6(7), 1639–1645 (2006).
- Hall IE, Yarlagadda SG, Coca SG et al. IL-18 and urinary NGAL predict dialysis and graft function after kidney transplantation. J. Am. Soc. Nephrol.21(1), 189–197 (2010).